Our results showed that exposure of the three NSCLC lines to plasma concentrations of paclitaxel (5 μM) produced an increase in MDR1 expression, while MRP3 showed no alteration in expression. The gene discussed is ABCB1; the disease is non-small cell lung carcinoma.